Article

Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating…

Evidence-Based Complementary and Alternative Medicine · 2015 · Yanli Xu, author Shan Xu, author Yueqin Cai, author Luming Liu, author Kuzhuvelil B. Harikumar, Academic Editor

Key facts

Title Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1
First author Yanli Xu, author Shan Xu, author Yueqin Cai, author Luming Liu, author Kuzhuvelil B. Harikumar, Academic Editor
Journal Evidence-Based Complementary and Alternative Medicine
Published Jul 1, 2015
DOI 10.1155/2015/145016
Devices mentioned K973350, K990827
Product codes mentioned JLX, KQP

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature